Elevance Health Inc [ELV] stock prices are up 2.44% to $381.93 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ELV shares have gain 1.91% over the last week, with a monthly amount glided 5.89%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Elevance Health Inc [NYSE: ELV] stock has seen the most recent analyst activity on January 08, 2026, when Wolfe Research upgraded its rating to a Outperform but kept the price target unchanged to $425 for it. Previously, Deutsche Bank downgraded its rating to Hold on December 19, 2025, and kept the price target unchanged to $320. On October 14, 2025, Goldman initiated with a Neutral rating. Argus downgraded its rating to a Hold. Leerink Partners downgraded its rating to a Market Perform but $310 remained the price target by the analyst firm on July 18, 2025. Robert W. Baird downgraded its rating to Neutral for this stock on April 15, 2025, but kept the price target unchanged to $529. In a note dated March 17, 2025, Argus upgraded an Buy rating on this stock but restated the target price of $450.
The stock price of Elevance Health Inc [ELV] has been fluctuating between $273.71 and $458.75 over the past year. Currently, Wall Street analysts expect the stock to reach $391 within the next 12 months. Elevance Health Inc [NYSE: ELV] shares were valued at $381.93 at the most recent close of the market. An investor can expect a potential return of 2.37% based on the average ELV price forecast.
Analyzing the ELV fundamentals
The Elevance Health Inc [NYSE:ELV] reported sales of 194.82B for trailing twelve months, representing a surge of 12.33%. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.13 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.73.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Elevance Health Inc [NYSE:ELV]’s Current Ratio is 1.56. Considering the valuation of this stock, the price to sales ratio is 0.44, the price to book ratio is 1.93 and price to earnings (TTM) ratio is 15.62.
Transactions by insiders
Recent insider trading involved DeVore Susan D., Director, that happened on Aug 19 ’25 when 1200.0 shares were purchased. President and CEO, BOUDREAUX GAIL completed a deal on Jul 18 ’25 to buy 8500.0 shares. Meanwhile, EVP & CFO Kaye Mark sold 4588.0 shares on Apr 24 ’25.
